current & emerging biomarkers in multiple myeloma
Published 2 years ago • 93 plays • Length 3:00Download video MP4
Download video MP3
Similar videos
-
2:01
ctcs as a biomarker of tumor burden in multiple myeloma
-
5:37
biomarkers in ultra low-risk myeloma
-
0:52
novel strategies to evaluate biomarkers of interest in multiple myeloma
-
1:49
circulating tumor dna as a biomarker in multiple myeloma: pitfalls and future outlooks
-
2:30
biomarkers of cardiotoxicity in multiple myeloma
-
1:38
the current and future management of myeloma in the second-line
-
2:17
mrd: a promising biomarker in multiple myeloma
-
4:58
overview of the toxicities associated with bispecific agents in multiple myeloma
-
6:23
how long will i live with multiple myeloma, and is there a cure? #myeloma
-
10:31
case study: discovery of biomarkers of immuno-oncology
-
1:05
ultrastratification of multiple myeloma via biomarkers
-
2:37
meta-analysis of studies on biomarker-defined early multiple myeloma
-
2:30
using biomarkers to identify molecular lesions and monitor response to treatment in multiple myeloma
-
2:06
an insight into the sequencing of car-t and bispecifics in myeloma
-
2:28
advancements in prognostic biomarkers for personalized therapy in multiple myeloma
-
6:58
current treatments and sequencing of agents in multiple myeloma
-
1:11
advances that have been made in the molecular characterization of multiple myeloma
-
1:12
using biomarkers and genomics to inform treatment strategy in all
-
2:23
dw-mri and serum biomarkers to assess tumor burden and bone loss in multiple myeloma
-
1:37
immune strategies in consolidation and maintenance for multiple myeloma
-
1:53
the future of multiple myeloma treatment